Sanofi will be the inaugural partner for the Scleroderma Research Foundation’s new clinical trial initiative to advance treatments for the rare autoimmune disorder of the skin and organs.
[Fierce Biotech]
Home Newsletters Dermal Cell News Scleroderma Clinical Trial Initiative Snags Sanofi as First Partner to Accelerate Research
